Gloucester Pharmaceuticals’ Istodax® (romidepsin) Receives FDA Approval to Treat Cutaneous T-cell Lymphoma
CATEGORIES News Events Publications ARCHIVE Gloucester Pharmaceuticals’ Istodax® (romidepsin) Receives FDA Approval to Treat Cutaneous T-cell Lymphoma I am pleased […]